The 3rd UMBC–Stanford Workshop
on Clinical Trials and Regulatory Science

Sponsors:

 a) Department of Mathematics and Statistics, UMBC

 b) Center for Innovative Study Design (CISD), Stanford University

 c) Center of Excellence in Regulatory Science and Innovation



Registration is now closed

Organizing Committee:

Faculty from UMBC and Stanford University and leaders from FDA and industry.

For more information: Please contact Dr. Yi Huang, Department of Mathematics and Statistics, University of Maryland Baltimore County (UMBC), 1000 Hilltop Circle, Baltimore, MD 21250.
E-Mail: yihuang@umbc.edu.

For any Technical difficulties Please contact Zana Coulibaly at czana1@umbc.edu.




Real World Evidence, Globalization, and Regulatory Science.
 
Date: Sept. 14-15, 2018
(Short-course on Sept. 14 afternoon, Conference on Sept. 15)
Location: UMBC, (ITE Building, Lecture Halls)
University of Maryland, Baltimore County
1000 Hilltop Circle, Baltimore, MD 21250

The 3rd UMBC-Stanford Workshop features a one-day conference (Saturday) with keynote speakers Dr. Janet Woodcock of the US FDA, Dr. Yuki Ando of the Japan PMDA, and Dr. Michael Krams of Janssen Pharmaceuticals, followed by panel discussions and parallel presentation sessions on prominent issues in drug development and regulatory science including real world data and globalization in drug regulation. There will be also a half-day (Friday afternoon) short course on “Innovations in group sequential designs and data monitoring” given by Dr. Keaven Anderson of Merck Research Laboratories. The unique feature of this conference is the direct dialogue among the leaders of regulatory agencies and industry from US and Asian countries on the innovations in regulatory sciences. Coffee breaks and lunch are included in Saturday conference. Networking event is open for all registered participants at Saturday. Welcome to UMBC!


Objectives: The UMBC-Stanford Workshop series aims to bring together regulators, academic researchers, and industry professionals to discuss prominent issues of common concerns, in clinical trials and to improve close collaborations to promote biomedical innovation in modern regulatory science.

Target audience: Regulatory scientists, statisticians, health policy professionals, clinicians, biopharmaceutical product development professionals, and other associated researchers.

Organization & Scientific Program Committees: Faculty from UMBC and Stanford University and leaders from FDA and industry.

Registration: Click here to register.
Regular registration for Sat. workshop: $199.
Short course registration: $100.
Dual registration for workshop and short course: $249
Government employees and local researchers from academia: $50;
Short course registration: $100;
Students with valid ID: $25 for workshop, $25 for short course.
Registration fee is waived for keynote speakers and personals from the sponsoring organizations (UMBC, Stanford University, FDA, and UM – CERSI).

For more information: Please contact Dr. Yi Huang, Department of Mathematics and Statistics, University of Maryland Baltimore County (UMBC), 1000 Hilltop Circle, Baltimore, MD 21250.
E-Mail: yihuang@umbc.edu.